Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Portland Health appoints new associate director Matt Worrall

He joins as the London health comms agency celebrates its first anniversary

- PMLiVE

Print health ad spend in US remains buoyant

Companies paid $45m on advertising in professional print journals in January 2014, a 7 per cent rise year-on-year

- PMLiVE

Interview: Georg Toufar, Mundipharma

Mundipharma’s chief marketing officer Georg Toufar on the benefits of having a smaller, more concentrated focus

- PMLiVE

GSK invests in African research and manufacturing

Boosts R&D for non-communicable diseases

Novartis day

Novartis’ dual-action heart failure drug aces trial

Ends LCZ696 trial early on good results

National Institute for Health and Care Excellence NICE logo

Final NICE ‘no’ for J&J’s Stelara in psoriatic arthritis

Committee says drug is more expensive and less effective than TNF alpha inhibitors

- PMLiVE

AZ teams up with UK’s MRC for discovery centre

Public-private facility will be based at the pharma company's Cambridge R&D site

08 UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

Havas Lynx

UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

Havas Lynx

- PMLiVE

Merck & Co appoints new financial head

Baxter’s Robert Davis takes over from Peter Kellogg

- PMLiVE

Certainty comes too late

In the first of a new regular column, Professor Brian D Smith points out the practical implications of an evolving pharma market

Novartis building

FDA panel rejects Novartis’ heart failure hope serelaxin

Decision follows EMA knock back earlier this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links